United States · Investor

Forward

Filed with the SEC to raise a fund in Dec 2023, closing $2M. Last cheque observed Oct 2018.

QuietNew fund $1.8M, Dec 2023Hedge fund

Series BArtificial IntelligenceHealth CareHealth Diagnostics

Cheques on record
0%of best year0cheques in 12 months, 3 on record
Since the last cheque2932days00hrs00min00sec
Median round$18MRounds led0 of 3
Pitch Forward

Forward highlights

  1. 01

    3 rounds on record

  2. 02

    Mostly Series B: 100% of its rounds

What they do

Type
Hedge fund (from a list, unverified)
Cheque size
Not stated
Sectors
Artificial IntelligenceHealth CareHealth Diagnostics
Based in
San Francisco, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first3 appearances

  1. 2018

    2 rounds

  2. Oct
    ThreadGB · Businessinsider$31MWith 2 others
  3. Mar
    DroverGB · FinSMEs$7.7MWith 4 others
  4. 2017

    1 round

  5. Apr
    Viracta TherapeuticsSeries B · US · FinSMEs$18MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration13 named

AHAlan Huaming ReidDIRECTOR OF GENERAL PARTNERiFiling they signed
BDBruce D. NeviaserExecutive OfficeriFiling they signed
CDChris D. HakeExecutive OfficeriFiling they signed
DHDavid Huaming ChouDIRECTOR OF GENERAL PARTNERiFiling they signed
DJDavid Joseph ChowDIRECTOR OF GENERAL PARTNERiFiling they signed
FAFredric A. DeVillersExecutive OfficeriFiling they signed
JJJames Joseph HalliganDIRECTOR OF GENERAL PARTNERiFiling they signed
JDJeffrey D. DeVillersExecutive OfficeriFiling they signed
MLMatthew LeedsExecutive Officer, PromoteriFiling they signed
RJRobert Joseph LebermanDIRECTOR OF GENERAL PARTNERiFiling they signed
TWThomas WoodhouseDIRECTOR OF GENERAL PARTNERiFiling they signed
TJToby Joseph RosenblattDIRECTOR OF GENERAL PARTNERiFiling they signed
WPWilliam PrezantDIRECTOR OF GENERAL PARTNERiFiling they signed

We also hold 17 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Recently backed

The latest companies Forward put money into.

Drover$7.7M · Mar 2018

Quick answers about Forward

What does Forward invest in?

Forward invests most often at Series B (100% of the rounds on record), in sectors such as Artificial Intelligence, Health Care and Health Diagnostics.

How active is Forward?

3 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2018.

What has Forward invested in recently?

Its most recent investments on record: Thread (Undisclosed round, Oct 2018), Drover (Undisclosed round, Mar 2018) and Viracta Therapeutics (Series B, Apr 2017).

How big are Forward's cheques?

The median round it joins is $18M.

Is Forward investing now?

No investments in the last 12 months; the latest was in Oct 2018.

What kind of investor is Forward?

Forward is a hedge fund based in San Francisco, United States.

Has Forward raised a new fund?

Its latest fund filing with the SEC was in Dec 2023, reporting $1.8M raised.

When was Forward founded?

Forward was founded in 2016.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it